🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
China flag China · Delayed Price · Currency is CNY
36.85
-2.01 (-5.17%)
Nov 20, 2026, 3:04 PM CST

SHE:300725 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
692.79532.74290.2511.191,150699.63
Short-Term Investments
15.81351.85618.48984.26303.46100.74
Trading Asset Securities
699.89735.57465.61105.35163.3304.43
Cash & Short-Term Investments
1,4081,6201,3741,6011,6171,105
Cash Growth
55.84%17.89%-14.15%-1.01%46.38%-19.79%
Accounts Receivable
470.29386.03483.69473.66330.61201.27
Other Receivables
4.762.991.922.621.832.11
Receivables
475.05389.02485.61476.28332.44203.38
Inventory
747.84655.24840.17724.79676.39447.94
Other Current Assets
150.9911.3416.8815.8833.847.89
Total Current Assets
2,7822,6762,7172,8182,6601,804
Property, Plant & Equipment
1,8161,6531,6841,7531,6611,173
Long-Term Investments
119.092,30319.865.485.668.91
Goodwill
355.74355.74355.74356.19356.19356.19
Other Intangible Assets
113.59103.59107.98109.42111.48111.47
Long-Term Deferred Tax Assets
41.3639.8232.6338.6135.815.1
Long-Term Deferred Charges
75.6510.136.9410.149.187.24
Other Long-Term Assets
130.91198.310.9913.122.830.74
Total Assets
5,4357,3404,9355,1044,8623,507

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
538.36312.75292.2278.7413.47267.35
Accrued Expenses
89.63111.291104.7188.1860.61
Short-Term Debt
-100.06230.27236.5163.4347.64
Current Portion of Long-Term Debt
--52.74371.4317.297.95
Current Portion of Leases
8.584.751.261.99-1.82
Current Income Taxes Payable
38.7414.6716.9615.70.850.15
Current Unearned Revenue
68.9170.2856.2832.7339.6328.7
Other Current Liabilities
7.938.118.5314.3316.3574.66
Total Current Liabilities
752.15621.82749.231,056739.18788.88
Long-Term Debt
--1,1271,1381,39223.6
Long-Term Leases
16.767.873.210.23--
Long-Term Unearned Revenue
41.744.846.6152.6452.8554.14
Long-Term Deferred Tax Liabilities
38.05365.2522.1324.3120.1512.58
Total Liabilities
848.661,0401,9482,2722,205879.21

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
233.81233.81199.73199.66199.66199.7
Additional Paid-In Capital
2,3382,3381,0961,0901,0751,299
Retained Earnings
1,9741,8241,5971,4391,261967.1
Treasury Stock
-30.04-30.04-30.04-20.03--35
Comprehensive Income & Other
70.941,935125.24123.52121.74-3.44
Total Common Equity
4,5866,3002,9882,8322,6582,427
Minority Interest
----0200.29
Shareholders' Equity
4,5866,3002,9882,8322,6582,628
Total Liabilities & Equity
5,4357,3404,9355,1044,8623,507

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
25.33112.671,4141,7491,573381.02
Net Cash (Debt)
1,3831,507-39.71-147.8344.11723.78
Net Cash Growth
72.87%----93.91%-42.42%
Net Cash Per Share
5.957.22-0.20-0.730.223.63
Filing Date Shares Outstanding
232.97232.97198.89198.83199.66199.7
Total Common Shares Outstanding
232.97232.97198.89198.83199.66199.7
Working Capital
2,0302,0541,9681,7621,9211,015
Book Value Per Share
19.6927.0415.0214.2413.3112.16
Tangible Book Value
4,1175,8412,5242,3672,1901,960
Tangible Book Value Per Share
17.6725.0712.6911.9010.979.81
Buildings
-949.96950.4905.31844.6344.88
Machinery
-1,3031,0521,025792.72510.13
Construction In Progress
-61.68232.68256.23357.53575.32